KAISA CAPITAL (00936) signed a strategic cooperation agreement with a technology company.
JiaZaoYe Capital (00936) announced that its wholly-owned subsidiary, Yiyu Asia Pacific Limited, recently entered into a strategic cooperation agreement with a technology company (partner) to establish a long-term cooperative relationship. The partner is a leading global AI computing power supplier, with pioneering domestically developed AI chip technology as its core, dedicated to providing a new generation of AI computing platforms with high performance, low latency, and high computing power cost-effectiveness. Both parties will integrate their respective core strengths to jointly expand the practical applications of domestic AI chips, computing power products, and supporting solutions in diverse industrial scenarios domestically and internationally.
KAISA CAPITAL (00936) announced that its wholly-owned subsidiary, Yi Yu Asia Pacific Limited, recently entered into a strategic cooperation agreement with a technology company (partner) to establish a long-term partnership. The partner is a global leading AI computing power supplier with innovative domestic self-developed AI chip technology at its core, committed to providing a new generation AI computing platform with high performance, low latency, and high computing power cost-effectiveness. Both parties will integrate their core advantages to jointly expand the practical applications of domestic AI chips, computing products, and supporting solutions in diversified industrial scenarios both domestically and internationally.
The Board of Directors believes that this strategic cooperation is a key move in the Group's strategic transformation. The Group will fully utilize its existing shareholder resources, industry expertise, and regional channel advantages, combined with the partner's cutting-edge technological strength. Both parties will jointly develop end-to-end intelligent solutions for real-world application scenarios, promoting the scale application of Physical AI (artificial intelligence) technology, further optimizing the Group's business portfolio and cultivating new profit growth points.
Related Articles

AI iteration speeds up again! Musk reveals that Grok 4.5 is already being internally tested at SpaceX and Tesla, Inc.

New stock first day | "First Stock of Innovative Drug for Kidney Disease" Libang Medicine (09637) Listed for the first time, surging nearly 97% in the early trading session.

New stock news | "The first AI hard technology stock with visual embodiment intelligence" Ruwei Technology (07656) is launching an IPO, adding high-quality targets to the Hong Kong stock AI hard technology track.
AI iteration speeds up again! Musk reveals that Grok 4.5 is already being internally tested at SpaceX and Tesla, Inc.

New stock first day | "First Stock of Innovative Drug for Kidney Disease" Libang Medicine (09637) Listed for the first time, surging nearly 97% in the early trading session.

New stock news | "The first AI hard technology stock with visual embodiment intelligence" Ruwei Technology (07656) is launching an IPO, adding high-quality targets to the Hong Kong stock AI hard technology track.

RECOMMEND





